Question 1

What is LOPJLB’s current signal on TCRT?

Accepted Answer

LOPJLB’s latest quantitative signal on Alaunos Therapeutics, Inc. (TCRT) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is TCRT in?

Accepted Answer

Alaunos Therapeutics, Inc. (TCRT) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does Alaunos Therapeutics, Inc. (TCRT) do?

Accepted Answer

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, …

Question 4

Where is Alaunos Therapeutics, Inc. based / listed?

Accepted Answer

Alaunos Therapeutics, Inc. is based in US, listed on NASDAQ.

Alaunos Therapeutics, Inc. (TCRT)

Key stats

Prediction markets

Company news

Congress trades

Congress trades